Molina Healthcare Inc (MOH) Valuation

The valuation picture for Molina Healthcare is highly contradictory. The provided GoodMoat Target of $3,021.52 suggests the stock is deeply undervalued by over 2,000%, which would far exceed the framework's 'Deeply Undervalued' band of >40% Margin of Safety. However, this target is astronomically high relative to the current price of $139.84 and the company's $7.2B market cap, indicating it is almost certainly a data error or placeholder and cannot be used for a reliable DCF-based assessment. Using standard multiples, the forward P/E of 15.2x is below the typical healthcare sector average (often in the low 20s), suggesting a discount. This could be viewed as favourable for a value investor if the business fundamentals were strong. The challenge is that several quality metrics conflict with a simple 'cheap' narrative. The company's Free Cash Flow Yield is negative at -8.8%, and its profit margins are very thin at 1.0% (net) and 1.7% (operating). These figures fail the framework's quality checks for strong, growing FCF and high margins. Therefore, while the P/E multiple looks inexpensive, the stock's valuation may reflect its lower quality and profitability profile rather than a clear bargain. A value investor must reconcile the seemingly cheap multiple with the underlying operational metrics that justify caution. Analysis based on data as of 2024-05-15.